Monday, November 21, 2016Statis Labs Raises $5M For Vital Signs MonitoringLos Angeles-based Statis Labs, a developer of vital signs monitoring equipment, has raised $5M in a seed funding round, the company said last week. The funding was led by RTP-HC, and also included Wonder Ventures, Techstars Ventures, and others. Milena Adamian, MD, of RTP-HC has joined the company's board as part of the funding. Statis Labs is a spinout of the University of Southern California (USC), and came out of CEO Dinesh Seemakurty's personal experience seeing a love one passed away due to (More info...)
posted on Monday, November 21, 2016(Full story)
Genalyte Finds $36MSan Diego-based biotech company Genalyte said this morning that it has raised $36M in a new funding round, for its efforts to develop a microchip-based testing platform. The funding was led by Khosla Ventures and Redmile Group. Genalyte is led by founder and CEO Cary Gunn. The company is initially targeting rheumatology offices with its technology.
posted on Monday, November 21, 2016 (More)(Full story)
Snapchat's Spectacles Bot Heads To New York City TodayVenice, California-based Snapchat is continuing to deploy its Snapbot automated vending machines for its Spectacles across the country, and has now opened a "pop up" store" focused on the glasses in New York City, after trips to the Rose Bowl and the Grand Canyon over the weekend. The location in New York City is the first time the glasses have been available on the East Coast. Snapchat is moving its Spectacles "Snapbot" vending machine everyday, only letting people find those vending machines o (More info...)
posted on Monday, November 21, 2016(Full story)
Mast Therapeutics Looks For BuyerSan Diego-based biopharmaceuticals developer Mast Therapeutics announced this morning that it is evaluating "strategic opportunities", and is considering a reverse merger, licensing of its assets, as well as continued clinical development of its lead compound. The company said it received "several written indications of interest" from private held companies in terms of a reverse merger. Mast Therapeutics is publicly traded on the NYSE at MSTX. The company has been investigating drugs for treati (More info...)
posted on Monday, November 21, 2016(Full story)
Dexcom Foundation Starts Awarding Diabetes GrantsThe Dexcom One Step Ahead Foundation, a new employee foundation run by employees of medical equipment products maker Dexcom said it has awarded the first grants out of the brand new foundation, to five public charity organizations. The foundation said the grants range from $10,000 to $50,000, and go to projects aimed at producing the most sustained benefits to the health and quality- of-life for people living with diabetes. Dexcom is a developer of glucose monitoring devices widely used by diabe (More info...)
posted on Monday, November 21, 2016(Full story)
Hyperloop One Settles Lawsuit With BamBrogan, OthersLos Angeles-based next generation transportation technology developer Hyperloop One said Friday that it has settled a lawsuit filed by former CTO Brogan BamBrogan and three others. Terms of the settlement were not disclosed. BamBrogan and three other former employees had filed suit against Hyperloop One--as well as a number of board members-- in July, and Hyperloop One had filed its own countersuit against BamBrogan for $250M.
posted on Monday, November 21, 2016(Full story)
aTyr Pharma Gets $20M Credit FacilitySan Diego-based biotherapeutics developer aTyr Pharma announced this morning that it has received a $20M credit facility. The credit facility came from Silicon Valley Bank and Solar Capital Ltd. Terms of that credit facility were not announced. The company said it will use the funding to pay off existing indebtedness and for general corporate purposes. aTyr Pharma is developing therapeutics addresses severe and rare diseases related to muscular dystrophy and other areas.
posted on Monday, November 21, 2016(Full story)